UB School of Management to Offer MBA Option in Biotechnology Management

By Jacqueline Ghosen

Release Date: November 6, 2003 This content is archived.


BUFFALO, N.Y. -- The University at Buffalo School of Management will offer a new MBA concentration in biotechnology management beginning in Fall 2004.

The curriculum is designed to provide a strong foundation of business principles vital to building a successful career in the biotechnology field.

A new course, "The Business of Biotechnology," will provide students with a solid understanding of the issues, strategies and technologies associated with this large and growing industry. A second new course, "Managing Intellectual Property," will focus on intellectual property rights and the impact of the regulatory process in the commercialization of technology-based products.

The biotechnology management track also features a required course in entrepreneurship and a semester-long internship with a company or organization in the industry.

In addition, students will complete core courses in organizational behavior; project planning, evaluation, financing, marketing and management; statistical analysis, and database management systems.

"The biotechnology management track will align the School of Management with UB's mission in this area and the commercialization of technology. It will position our students on the leading edge of this emerging field, whether their goal is to be involved as entrepreneurs in biotech ventures or they wish pursue management careers with large biotech or pharmaceutical firms," said School of Management Dean John M. Thomas.

The University at Buffalo School of Management is ranked as one of the world's top-50 business schools by The Wall Street Journal. It also has been cited by Business Week as one of the "best business schools" in America, and by Forbes for "best return on investment." For more information about the UB School of Management, visit http://www.mgt.buffalo.edu.